Wayne, N.J.-based medical device company Cascade Medical Enterprises has sold its technology for platelet-rich plasma and platelet-rich fibrin matrix to Musculoskeletal Transplant Foundation, according to a Cascade Medical news release.
Cascade Medical had a U.S. distribution relationship with MTF prior to this sale. The company's Cascade System will now be distributed by ConMed Linvatec. The system is cleared by the FDA and designed for use in the preparation of autologous PRP from a sample of the patient's blood. The PRP can also be mixed with autograft and allograft bone before applying it to a surgical site.
The proprietary aspect of the technology is its ability to produce liquid, gel and membrane formats for PRP.
Related Articles on Orthopedic Devices:
Wright Medical Group Launches Foot and Ankle Systems
Synthes Takes on 3 Former Sales Reps, Stryker in Loyalties Case
Symmetry Medical Completes Acquisition of Surgical Implants Company
The proprietary aspect of the technology is its ability to produce liquid, gel and membrane formats for PRP.
Related Articles on Orthopedic Devices:
Wright Medical Group Launches Foot and Ankle Systems
Synthes Takes on 3 Former Sales Reps, Stryker in Loyalties Case
Symmetry Medical Completes Acquisition of Surgical Implants Company